Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease.
Adult
Antiphospholipid Syndrome
/ diagnostic imaging
Area Under Curve
Behcet Syndrome
/ diagnostic imaging
Case-Control Studies
Female
Femoral Vein
/ diagnostic imaging
Humans
Logistic Models
Male
Observer Variation
Predictive Value of Tests
ROC Curve
Sensitivity and Specificity
Spondylitis, Ankylosing
/ diagnostic imaging
Statistics, Nonparametric
Systemic Vasculitis
/ diagnostic imaging
Ultrasonography, Doppler
Venous Insufficiency
/ diagnostic imaging
Venous Thrombosis
/ diagnostic imaging
Behçet’s disease
diagnostic
ultrasonography
venous vascular imaging
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
05 01 2021
05 01 2021
Historique:
received:
12
02
2020
revised:
21
04
2020
pubmed:
7
8
2020
medline:
17
4
2021
entrez:
7
8
2020
Statut:
ppublish
Résumé
Diagnosing Behçet's disease (BD) is a challenge, especially in countries with a low prevalence. Recently, venous wall thickness (VWT) in lower extremities has been shown to be increased in BD patients. In this study, we aimed to investigate the diagnostic performance of common femoral vein (CFV) thickness measurement in BD and whether it can be used as a diagnostic tool. . Patients with BD (n = 152), ankylosing spondylitis (n = 27), systemic vasculitides (n = 23), venous insufficiency (n = 29), antiphospholipid syndrome (APS; n = 43), deep vein thrombosis due to non-inflammatory causes (n = 25) and healthy controls (n = 51) were included in the study. Bilateral CFV thickness was measured with ultrasonography by a radiologist blinded to cases. Bilateral CFV thickness was significantly increased in BD compared with all control groups (P < 0.001 for all). The area under the receiver operating characteristic curve for bilateral CFV thicknesses in all comparator groups was >0.95 for the cut-off value (0.5 mm). This cut-off value also performed well against all control groups with sensitivity rates >90%. The specificity rate was also >80% in all comparator groups except APS (positive predictive value: 79.2-76.5%, negative predictive value: 92-91.8% for right and left CFV, respectively). Increased CFV thickness is a distinctive feature of BD and is rarely present in healthy and diseased controls, except APS. Our results suggest that CFV thickness measurement with ultrasonography, a non-invasive radiological modality, can be a diagnostic tool for BD with sensitivity and the specificity rates higher than 80% for the cut-off value ≥0.5 mm.
Identifiants
pubmed: 32756998
pii: 5881458
doi: 10.1093/rheumatology/keaa264
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
288-296Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.